10:32 AM EST - Medicenna Therapeutics Corp. : Announced its financial results and operational highlights for the quarter ended September 30, 2022. Net loss was $0.9 million, or ($0.01) per share, compared to a loss of $8.2 million, or ($0.15) per share for the quarter ended September 30, 2021. Medicenna Therapeutics Corp.
shares T.MDNA are trading down $0.02 at $0.90.
